住院急性肾损伤幸存者出院后照护过程:基于人群的队列研究
该研究在加拿大阿尔伯塔省纳入23,921例住院期间发生KDIGO 2期或3期急性肾损伤或需急性透析的成人,回顾性随访至出院后90天及后续1年。结果显示出院后90天内血肌酐检测、白蛋白尿评估及肾脏科随访比例均较低,合并慢性肾脏病者出院后4-15个月RAAS抑制剂处方比例约半数。
要点
- 出院后90天内仅60.1%的AKI幸存者至少检测1次血肌酐。
- 出院后90天内仅25.5%的AKI幸存者接受了白蛋白尿评估。
- 合并慢性肾脏病者出院后4-15个月RAAS抑制剂处方比例约半数。
核心结论
- 在阿尔伯塔省,急性肾损伤发作后接受最佳照护的患者比例较低,可能代表改善该人群长期结局的靶点。
研究设计与样本
- 基于人群的回顾性队列研究,纳入2009至2017年在加拿大阿尔伯塔省住院的成人,从出院日期随访至2019年,中位随访2.7年。
- 暴露为符合KDIGO血清肌酐标准的2期或3期医院获得性急性肾损伤,或需要急性透析。
- 队列共23,921例,男性占50.2%(n=12,015),中位年龄68.1岁(IQR 56.9-78.8)。
主要发现
- 出院后90天内,有既存慢性肾脏病者21.2%、无既存慢性肾脏病者8.6%看过肾脏科医生。
- 出院后90天内,60.1%的AKI幸存者至少检测1次血肌酐,仅25.5%接受了白蛋白尿评估。
- 出院后4-15个月内,有既存慢性肾脏病者52.7%、新发慢性肾脏病者51.6%被处方RAAS抑制剂。
关键数值与推荐
- 原文未报告具体推荐条款或阈值。
临床怎么用
- 原文未报告临床实践建议。
局限性
- 回顾性数据作为常规临床照护的一部分收集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Survivors of acute kidney injury (AKI) are at high risk of adverse outcomes. Monitoring of kidney function, screening for proteinuria, use of statins and renin-angiotensin-aldosterone system (RAAS) inhibitors, and nephrology follow-up among survivors have not been fully characterized. We examined these processes of care after discharge in survivors of hospitalized AKI. STUDY DESIGN: Population-based retrospective cohort study. SETTING & PARTICIPANTS: Adults in Alberta, Canada, admitted to the hospital between 2009 and 2017, then followed from their discharge date until 2019 for a median follow-up of 2.7 years. EXPOSURE: Hospital-acquired AKI diagnostically conforming to Kidney Disease: Improving Global Outcomes (KDIGO) serum creatinine criteria for stage 2 or stage 3 disease, or the need for acute dialysis. OUTCOME: Outcomes after hospital discharge included the proportion of participants who had evaluation of kidney function, were seen by a specialist or general practitioner, and received postdischarge prescriptions for recommended medications for chronic kidney disease (CKD). ANALYTICAL APPROACH: Cumulative incidence curves to characterize the proportion of participants who received each process of care outcome within the first 90 days and subsequent 1-year follow-up period after hospital discharge. To avoid risks associated with multiple hypothesis testing, differences were not statistically compared across groups. RESULTS: The cohort (n=23,921) included 50.2% men (n=12,015) with a median age of 68.1 [IQR, 56.9-78.8] years. Within 90 days after discharge, 21.2% and 8.6% of patients with and without pre-existing CKD, respectively, were seen by a nephrologist; 60.1% of AKI survivors had at least 1 serum creatinine measured, but only 25.5% had an assessment for albuminuria within 90 days after discharge; 52.7% of AKI survivors with pre-existing CKD, and 51.6% with de novo CKD were prescribed a RAAS inhibitor within 4-15 months after discharge. LIMITATIONS: Retrospective data were collected as part of routine clinical care. CONCLUSIONS: The proportion of patients receiving optimal care after an episode of AKI in Alberta was low and may represent a target for improving long-term outcomes for this population. PLAIN-LANGUAGE SUMMARY: A study in Alberta, Canada, examined the care received by patients with acute kidney disease (AKI) during hospitalization and after discharge between 2007 and 2019. The results showed that a low proportion of patients with moderate to severe AKI were seen by a kidney specialist during hospitalization or within 90 days after discharge. Fewer than 25% of AKI patients had their kidney function monitored with both blood and urine tests within 90 days of discharge. Additionally, about half of AKI survivors with chronic kidney disease (CKD) were prescribed guideline recommended medications for CKD within 15 months after discharge. There is potential to improve health care delivery to these patients both in hospital and after hospital discharge.
引用
- Brar S, Ye F, James MT, et al. Processes of Care After Hospital Discharge for Survivors of Acute Kidney Injury: A Population-Based Cohort Study. Am J Kidney Dis. 2023. PMID: 37734688. doi:10.1053/j.ajkd.2023.07.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。